In today’s fast-paced world, mental clarity, focus, and memory retention are essential for success. Whether you’re a student, ...

Recently, the research team led by Professor Zhang Zhongtao and Professor Yao Hongwei from the General Surgery Center at ...

Omeros has announced that the activation of clinical trial sites for patient enrolment is now in progress for its Phase III ...

Actuate Therapeutics' elraglusib shows promise for pancreatic cancer, but financial instability and risks make it a high-risk ...

CervoMed's stock soars 400% on promising dementia drug data. See more on insights, potential concerns, and what it means for ...

Fish oil supplements, delivering higher EPA doses, significantly reduced the number and procoagulant activity of ...

New�Analyses from the Phase 3 ASPEN Study Examining Efficacy and Safety of Brensocatib Across a Variety of Prespecified Subgroups� �Data on Health Status Improvements Over Time Following Culture ...

DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing novel treatments for acute ischemic stroke and preeclampsia, today provided a business update and ...

explored the role of cyclin-dependent kinase 5 (Cdk5) in modulating synaptic plasticity during the early stages of Huntington's disease (HD). Cdk5 is a serine/threonine kinase involved in various ...